References
- Alberts D. S., Peng Y., Chen H. S., Moon T. E., Cetas T. C., Hoeschele J. D. Therapeutic synergism of hyperthermia-cis-platinum in a mouse tumor model. Journal of the National Cancer Institute 1980; 65: 455–461
- Barlogie B., Corry P. M., Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Research 1980; 40: 1165–1168
- Bowden G. T., Kasunic M., Sim D. Sequence dependence for the hyperthermic potentiation of cis-diamminedichloroplatinum(II) induced cytotoxicity and DNA damage (Abstract). Proceedings of the Radiation Research Society February, 1983; 145
- Bull J. M. C. An update on the anticancer effects of a combination of chemotherapy and hyperthermia. Cancer Research 1984; 44: 4853s–4856s
- Douple E. B., Strohbehn J. S., de Sieyes D. C., Alborough D. P., Trembley B. S. Therapeutic potentiation of cis-dichlorodiamminepiatinum(II) and radiation by interstitial microwave hyperthermia in a mouse tumor. National Cancer Institute Monograph 1982; 61: 259–262
- Fisher G. A., Hahn G. M. Enhancement of cis-platimum(II) diamminedichloride cytotoxicity by hyperthermia. National Cancer Institute Monograph 1982; 61: 255–257
- Gerner E. W. Thermotolerance. Hyperthermia in Cancer Therapy, F. K. Storm. G. K. Hall, Boston, MA 1983; 141–162
- Hahn G. M. Potential for therapy of drugs and hyperthermia. Cancer Research 1979; 39: 2264–2268
- Herman T. S. Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytoxicity in vitro. Cancer Research 1983; 43: 517–520
- Herman T. S., Sweets C. C., White D. M., Gerner E. W. Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs. Journal of the National Cancer Institute 1982; 68: 487–491
- Ishida A., Mizuno S. Effects of hyperthermia and ethanol on the cytotoxicity of bleomycin, adriamycin. cis-diamrninedichloroplatinum(II) and macromomycin toward Hela cells. Gann 1982; 73: 129–131
- Marmor J. B. Interactions of hyperthermia and chemotherapy in animals. Cancer Research 1979; 39: 2269–2276
- Meyn R. E., Corry P. M., Fletcher S. E., Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis-diamminedichloroplatinum(II). Cancer Research 1980; 40: 1136–1139
- Oken M. M., Creech R. H., Tormey D. C., Horton J., Davis T. E., McFadden E. T., Carbone P. P. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology (CCT) 1982; 5: 649–655
- Oleson J. R., Dewhirst M. W. Hyperthermia: an overview of current progress and problems. Current Problems in Cancer 1983; 8: 1–62
- Roizin-Towle L., Hall E. J., Capuano L. Interaction of hyperthermia and cytotoxic agents. National Cancer Institute Monograph 1982; 61: 149–151
- Shrivastava P. R., Luk K., Oleson J., Dewhirst M., Pajak T., Paliwal B., Perez C., Sapareto S., Saylor T., Steeves R. Hyperthermia quality assurance guidelines. International Journal of Radiation Oncology, Biology and Physics 1987, (submitted)
- Stewart J. R., Bagshaw M. A., Corry P. M., Gerner E. W., Gibbs F. A., Hahn G. M., Lele P. P., Oleson J. R. Hyperthermia as a treatment of cancer. Cancer Treatment Symposia 1984; 1: 135–145
- Wallner K. E., Li G. C. Effect of drug exposure duration and sequencing on hyperthermic potentiation of mitomycin-C and cisplatin. Cancer Research 1987; 47: 493–495